Targeting aerosol deposition in patients with cystic fibrosis

Effects of alterations in particle size and inspiratory flow rate

Beth L Laube, R. Jashnani, R. N. Dalby, P. L. Zeitlin

Research output: Contribution to journalArticle

Abstract

Study objective: To determine if aerosolized medications can be targeted to deposit in the smaller, peripheral airways or the larger, central airways of adult cystic fibrosis (CF) patients by varying particle size and inspiratory flow rate. Design: Randomized clinical trial. Setting: Outpatient research laboratory. Patients: Nine adult patients with CF. Interventions: Patients inhaled an aerosol comprised of 3.68 ± 0.04 μm saline solution droplets (two visits) or 1.01 ± 0.2 μm saline solution droplets (two visits) for 30 s, starting from functional residual capacity and breathing at a slow or faster inspiratory flow rate. On all visits, the saline solution was admixed with the radioisotope 99mTc. Immediately after inhalation, a gamma camera recorded the deposition pattern of the radioaerosol in the lungs. Deposition images were analyzed in terms of the inner:outer zone (I:O) ratio, a measure of deposition in an inner zone (large, central airways) vs an outer zone (small airways and alveoli). Measurements and results: For the 3.68-μm aerosol, I:O ratios averaged 2.29 ± 1.45 and 2.54 ± 1.48 (p > 0.05), indicating that aerosol distribution within the lungs was unchanged while breathing at 12 ± 2 L/min vs 31 ± 5 L/min, respectively. For the 1.01-μm aerosol, I:O ratios averaged 2.09 ± 0.96 and 3.19 ± 1.95 (p <0.05), indicating that deposition was predominantly in the smaller airways while breathing at 18 ± 5 L/min and in the larger airways while breathing at 38 ± 8 L/min, respectively. Conclusions: These results suggest that the targeted delivery of an aerosol to the smaller, peripheral airways or the larger, central airways of adult CF patients may be achieved by generating an aerosol comprised of approximately 1.0-μm particles and inspiring from functional residual capacity at approximately 18 L/min and ~ 38 L/min, respectively.

Original languageEnglish (US)
Pages (from-to)1069-1076
Number of pages8
JournalChest
Volume118
Issue number4
StatePublished - 2000

Fingerprint

Aerosols
Particle Size
Cystic Fibrosis
Respiration
Sodium Chloride
Functional Residual Capacity
Lung
Gamma Cameras
Radioisotopes
Inhalation
Outpatients
Randomized Controlled Trials
Research

Keywords

  • Aerosols
  • Cystic fibrosis
  • Gene therapy
  • Inspiratory flow rate
  • Particle size

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Targeting aerosol deposition in patients with cystic fibrosis : Effects of alterations in particle size and inspiratory flow rate. / Laube, Beth L; Jashnani, R.; Dalby, R. N.; Zeitlin, P. L.

In: Chest, Vol. 118, No. 4, 2000, p. 1069-1076.

Research output: Contribution to journalArticle

@article{f9da2675b3b8466e9dc3ef5b22ab4c8d,
title = "Targeting aerosol deposition in patients with cystic fibrosis: Effects of alterations in particle size and inspiratory flow rate",
abstract = "Study objective: To determine if aerosolized medications can be targeted to deposit in the smaller, peripheral airways or the larger, central airways of adult cystic fibrosis (CF) patients by varying particle size and inspiratory flow rate. Design: Randomized clinical trial. Setting: Outpatient research laboratory. Patients: Nine adult patients with CF. Interventions: Patients inhaled an aerosol comprised of 3.68 ± 0.04 μm saline solution droplets (two visits) or 1.01 ± 0.2 μm saline solution droplets (two visits) for 30 s, starting from functional residual capacity and breathing at a slow or faster inspiratory flow rate. On all visits, the saline solution was admixed with the radioisotope 99mTc. Immediately after inhalation, a gamma camera recorded the deposition pattern of the radioaerosol in the lungs. Deposition images were analyzed in terms of the inner:outer zone (I:O) ratio, a measure of deposition in an inner zone (large, central airways) vs an outer zone (small airways and alveoli). Measurements and results: For the 3.68-μm aerosol, I:O ratios averaged 2.29 ± 1.45 and 2.54 ± 1.48 (p > 0.05), indicating that aerosol distribution within the lungs was unchanged while breathing at 12 ± 2 L/min vs 31 ± 5 L/min, respectively. For the 1.01-μm aerosol, I:O ratios averaged 2.09 ± 0.96 and 3.19 ± 1.95 (p <0.05), indicating that deposition was predominantly in the smaller airways while breathing at 18 ± 5 L/min and in the larger airways while breathing at 38 ± 8 L/min, respectively. Conclusions: These results suggest that the targeted delivery of an aerosol to the smaller, peripheral airways or the larger, central airways of adult CF patients may be achieved by generating an aerosol comprised of approximately 1.0-μm particles and inspiring from functional residual capacity at approximately 18 L/min and ~ 38 L/min, respectively.",
keywords = "Aerosols, Cystic fibrosis, Gene therapy, Inspiratory flow rate, Particle size",
author = "Laube, {Beth L} and R. Jashnani and Dalby, {R. N.} and Zeitlin, {P. L.}",
year = "2000",
language = "English (US)",
volume = "118",
pages = "1069--1076",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "4",

}

TY - JOUR

T1 - Targeting aerosol deposition in patients with cystic fibrosis

T2 - Effects of alterations in particle size and inspiratory flow rate

AU - Laube, Beth L

AU - Jashnani, R.

AU - Dalby, R. N.

AU - Zeitlin, P. L.

PY - 2000

Y1 - 2000

N2 - Study objective: To determine if aerosolized medications can be targeted to deposit in the smaller, peripheral airways or the larger, central airways of adult cystic fibrosis (CF) patients by varying particle size and inspiratory flow rate. Design: Randomized clinical trial. Setting: Outpatient research laboratory. Patients: Nine adult patients with CF. Interventions: Patients inhaled an aerosol comprised of 3.68 ± 0.04 μm saline solution droplets (two visits) or 1.01 ± 0.2 μm saline solution droplets (two visits) for 30 s, starting from functional residual capacity and breathing at a slow or faster inspiratory flow rate. On all visits, the saline solution was admixed with the radioisotope 99mTc. Immediately after inhalation, a gamma camera recorded the deposition pattern of the radioaerosol in the lungs. Deposition images were analyzed in terms of the inner:outer zone (I:O) ratio, a measure of deposition in an inner zone (large, central airways) vs an outer zone (small airways and alveoli). Measurements and results: For the 3.68-μm aerosol, I:O ratios averaged 2.29 ± 1.45 and 2.54 ± 1.48 (p > 0.05), indicating that aerosol distribution within the lungs was unchanged while breathing at 12 ± 2 L/min vs 31 ± 5 L/min, respectively. For the 1.01-μm aerosol, I:O ratios averaged 2.09 ± 0.96 and 3.19 ± 1.95 (p <0.05), indicating that deposition was predominantly in the smaller airways while breathing at 18 ± 5 L/min and in the larger airways while breathing at 38 ± 8 L/min, respectively. Conclusions: These results suggest that the targeted delivery of an aerosol to the smaller, peripheral airways or the larger, central airways of adult CF patients may be achieved by generating an aerosol comprised of approximately 1.0-μm particles and inspiring from functional residual capacity at approximately 18 L/min and ~ 38 L/min, respectively.

AB - Study objective: To determine if aerosolized medications can be targeted to deposit in the smaller, peripheral airways or the larger, central airways of adult cystic fibrosis (CF) patients by varying particle size and inspiratory flow rate. Design: Randomized clinical trial. Setting: Outpatient research laboratory. Patients: Nine adult patients with CF. Interventions: Patients inhaled an aerosol comprised of 3.68 ± 0.04 μm saline solution droplets (two visits) or 1.01 ± 0.2 μm saline solution droplets (two visits) for 30 s, starting from functional residual capacity and breathing at a slow or faster inspiratory flow rate. On all visits, the saline solution was admixed with the radioisotope 99mTc. Immediately after inhalation, a gamma camera recorded the deposition pattern of the radioaerosol in the lungs. Deposition images were analyzed in terms of the inner:outer zone (I:O) ratio, a measure of deposition in an inner zone (large, central airways) vs an outer zone (small airways and alveoli). Measurements and results: For the 3.68-μm aerosol, I:O ratios averaged 2.29 ± 1.45 and 2.54 ± 1.48 (p > 0.05), indicating that aerosol distribution within the lungs was unchanged while breathing at 12 ± 2 L/min vs 31 ± 5 L/min, respectively. For the 1.01-μm aerosol, I:O ratios averaged 2.09 ± 0.96 and 3.19 ± 1.95 (p <0.05), indicating that deposition was predominantly in the smaller airways while breathing at 18 ± 5 L/min and in the larger airways while breathing at 38 ± 8 L/min, respectively. Conclusions: These results suggest that the targeted delivery of an aerosol to the smaller, peripheral airways or the larger, central airways of adult CF patients may be achieved by generating an aerosol comprised of approximately 1.0-μm particles and inspiring from functional residual capacity at approximately 18 L/min and ~ 38 L/min, respectively.

KW - Aerosols

KW - Cystic fibrosis

KW - Gene therapy

KW - Inspiratory flow rate

KW - Particle size

UR - http://www.scopus.com/inward/record.url?scp=0033786617&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033786617&partnerID=8YFLogxK

M3 - Article

VL - 118

SP - 1069

EP - 1076

JO - Chest

JF - Chest

SN - 0012-3692

IS - 4

ER -